STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-04-19
Here’s whether DexCom, Inc. (DXCM) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: RSI 57 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-2.72% over 10 days); 3-month momentum negative (-8.0%). Currently 28.9% off its 52-week high. Score: -4/7.
DXCM is trading below its 200-day MA ($70.63) — a key warning sign the longer-term trend is under pressure. An RSI of 56.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -6.9% compares to +35.1% for SPY (trailed the market by 42.0%). The current 28.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $9,309 today
vs. S&P 500 (SPY) — same period trailed market by 42.0%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($70.63)
✗Above 50-day MA ($67.51)
✓RSI(14) neutral zone (30–70) — currently 56.7
✗Positive return (-6.9%)
!Within 10% of period high (−28.9%)
Period Range $63.98
$54.11$89.98
RSI (14) 56.7
0 · OversoldOverbought · 100
Key Metrics
Price$63.98
Period Return-6.9%
Period High$89.98
Period Low$54.11
Drawdown−28.9%
MA-50$67.51
MA-200$70.63
RSI (14)56.7
Avg Volume (30d)4.2M
vs. SPYtrailed by 42.0%
Return Rank#738 of 996
Trend Signals
Price is below the 200-day moving average ($70.63)